Bioresorbable coronary stent for the treatment of complex coronary lesions: Data from an all-comer registry

The use of BVS in an all-comers registry of patients undergoing coronary angioplasty on complex coronary lesions is associated with a safety profile comparable to that obtained with EES; the use of BVS in particular conditions, such as very high SYNTAX score, should be further assessed.